Cumberland Pharmaceuticals CPIX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.4M-125% | -$2.86M+55.5% | -$3.34M+69.2% | -$2.93M+71.8% | -$3.29M+60.8% | ||
| $4.39M-8.2% | $4.15M-15.4% | $4.6M-0.9% | $4.68M-1.9% | $4.78M-1.0% | ||
| $440.95K+48.3% | $408.32K+35.3% | $310.97K-3.1% | $306.08K-6.6% | $297.35K-15.9% | ||
| $23K-23.0% | $23.19K-18.1% | $25.02K+7.9% | $30.38K+85.6% | $29.87K+98.6% | ||
| $3.77M— | $5.24M— | -$880.02K— | —— | —— | ||
| -$2.19M+35.3% | -$2.45M+5.1% | -$3.78M-372% | -$3.15M-117% | -$3.38M— | ||
| $5.96M— | $6.71M— | -$1.66M— | —— | —— | ||
| -$91.95K— | $231.83K— | —— | —— | —— | ||
| -$386.52K— | -$477.64K— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| $1.14M0.0% | $1.14M0.0% | $1.14M+16.3% | $1.14M+21.8% | $1.14M+20.4% | ||
| -$841.96K-147% | -$836.1K-147% | $1.77M-66.5% | $1.77M-59.1% | $1.78M-47.4% | ||
| —— | —— | -$431.5K+63.2% | -$934.91K+23.3% | -$1.19M+2.6% | ||
| $1.42M— | $4.93M— | —— | —— | —— | ||
| $50.27K-30.6% | $97.9K+47.3% | $100.19K-11.2% | $91.78K-39.1% | $72.47K-66.4% | ||
| $85.36K-25.7% | $84.4K-25.5% | $65.09K-48.7% | $89.17K-34.5% | $114.89K-5.2% | ||
| -$3.83M— | -$4.99M— | —— | —— | —— | ||
| $78.61K-86.4% | $263.48K-54.5% | $361.86K-46.0% | $450.24K-41.7% | $577.31K-27.9% | ||
| —— | —— | —— | —— | $38.33M+11.2% | ||
| $1.9M+19.3% | $1.71M-0.2% | $1.5M-38.0% | $1.56M-35.9% | $1.6M-34.4% | ||
| -$1.98M— | -$6.75M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $441.68K-22.4% | $473.57K-19.6% | $505.45K-16.9% | $537.34K-14.4% | ||
| —— | -$3.53K-124% | $1.11K-97.1% | $5.74K-90.7% | $10.37K-87.9% | ||
| $23K-23.0% | $23.19K-18.1% | $25.02K+7.9% | $30.38K+85.6% | $29.87K+98.6% | ||
| —— | —— | -$431.5K+63.2% | -$934.91K+23.3% | -$1.19M+2.6% | ||
| —— | -$13.22K— | -$9.92K— | -$6.61K— | -$3.31K— | ||
| —— | —— | —— | —— | —— | ||
| -$841.96K-147% | -$836.1K-147% | $1.77M-66.5% | $1.77M-59.1% | $1.78M-47.4% | ||
| -$386.52K— | -$477.64K— | —— | —— | —— | ||
| -$91.95K— | $231.83K— | —— | —— | —— | ||
| $1.14M0.0% | $1.14M0.0% | $1.14M+16.3% | $1.14M+21.8% | $1.14M+20.4% | ||
| —— | —— | —— | —— | —— | ||
| $85.36K-25.7% | $84.4K-25.5% | $65.09K-48.7% | $89.17K-34.5% | $114.89K-5.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2M— | $1.5M— | $1M— | $500K— | ||
| —— | —— | —— | —— | -$5.27M— | ||
| —— | —— | —— | —— | $38.33M+11.2% | ||
| —— | $62+100% | -$17.38K+50.4% | -$34.82K-9,848% | -$52.26K-252% | ||
| -$841.96K-147% | -$836.1K-147% | $1.77M-66.5% | $1.77M-59.1% | $1.78M-47.4% | ||
| —— | $2M— | $1.5M— | $1M— | $500K— | ||
| $1.9M+19.3% | $1.71M-0.2% | $1.5M-38.0% | $1.56M-35.9% | $1.6M-34.4% | ||
| —— | $4.73K+792% | $3.68K+129% | $2.63K+110% | $1.58K+104% | ||
| —— | —— | —— | —— | —— | ||
| —— | $836.1K-3.2% | $842.91K-0.7% | $849.71K+1.9% | $856.52K+4.5% | ||
| —— | -$3.53K-124% | $1.11K-97.1% | $5.74K-90.7% | $10.37K-87.9% | ||
| $1.37M— | $4.83M— | —— | —— | —— | ||
| $1.37M— | $4.83M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cumberland Pharmaceuticals generate?
- Cumberland Pharmaceuticals (CPIX) generated $1.4M in operating cash flow over the trailing twelve months.
- What is Cumberland Pharmaceuticals's free cash flow?
- After $50.3K of capital expenditures, Cumberland Pharmaceuticals's free cash flow was $1.4M over the trailing twelve months, down 23.9% year over year.
- Where does Cumberland Pharmaceuticals's cash flow data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
